Intuitive Surgical, Inc. (NASDAQ:ISRG) – Analysts at Wedbush issued their FY2019 earnings estimates for Intuitive Surgical in a report issued on Tuesday. Wedbush analyst Levy. T forecasts that the medical equipment provider will post earnings per share of $25.64 for the year. Wedbush has a “Outperform” rating and a $835.00 price target on the stock.
Several other equities analysts have also commented on ISRG. BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Thursday. Canaccord Genuity reaffirmed a “buy” rating and set a $870.00 target price (up from $800.00) on shares of Intuitive Surgical in a report on Wednesday. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday. Barclays PLC reaffirmed a “buy” rating and set a $830.00 target price (up from $800.00) on shares of Intuitive Surgical in a report on Wednesday. Finally, Stifel Nicolaus upped their target price on Intuitive Surgical from $800.00 to $850.00 and gave the company a “buy” rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and eleven have given a buy rating to the company’s stock. Intuitive Surgical has a consensus rating of “Buy” and an average target price of $771.97.
TRADEMARK VIOLATION NOTICE: “Wedbush Comments on Intuitive Surgical, Inc.’s FY2019 Earnings (ISRG)” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/2485789/wedbush-comments-on-intuitive-surgical-inc-s-fy2019-earnings-isrg.html.
Intuitive Surgical (NASDAQ:ISRG) traded down 0.14% on Friday, hitting $813.31. The stock had a trading volume of 325,942 shares. Intuitive Surgical has a 12-month low of $610.71 and a 12-month high of $817.20. The firm has a market cap of $31.55 billion, a PE ratio of 43.42 and a beta of 0.55. The company’s 50 day moving average is $756.42 and its 200 day moving average is $694.18.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 18th. The medical equipment provider reported $5.09 EPS for the quarter, beating analysts’ consensus estimates of $3.97 by $1.12. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. The business had revenue of $674.20 million for the quarter, compared to the consensus estimate of $664.72 million. During the same quarter in the prior year, the business posted $4.42 EPS. The business’s revenue for the quarter was up 13.4% on a year-over-year basis.
A number of large investors have recently added to or reduced their stakes in ISRG. Acropolis Investment Management LLC acquired a new position in Intuitive Surgical during the first quarter valued at $115,000. Bessemer Group Inc. increased its position in Intuitive Surgical by 96.0% in the fourth quarter. Bessemer Group Inc. now owns 196 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 96 shares during the last quarter. Huntington National Bank increased its position in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares during the last quarter. Stephens Inc. AR increased its position in Intuitive Surgical by 77.1% in the third quarter. Stephens Inc. AR now owns 255 shares of the medical equipment provider’s stock valued at $185,000 after buying an additional 111 shares during the last quarter. Finally, Koch Industries Inc. acquired a new position in Intuitive Surgical during the fourth quarter valued at $205,000. Hedge funds and other institutional investors own 91.16% of the company’s stock.
In other Intuitive Surgical news, CFO Marshall Mohr sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, February 2nd. The stock was sold at an average price of $700.00, for a total value of $1,400,000.00. Following the completion of the sale, the chief financial officer now directly owns 3,289 shares in the company, valued at $2,302,300. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 15th. The stock was sold at an average price of $750.00, for a total value of $750,000.00. Following the completion of the sale, the director now owns 3,460 shares of the company’s stock, valued at $2,595,000. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,118 shares of company stock valued at $25,064,571. Insiders own 3.10% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.